GHK-Cu vs Tripeptide-10 Citrulline
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Copper Peptide, Glycyl-L-histidyl-L-lysine copper
GHK-Cu is the copper(II) complex of GHK, a naturally occurring human tripeptide (glycyl-L-histidyl-L-lysine) found in blood plasma, saliva and urine, whose levels decline with age. It is researched and widely used in cosmetic skincare for skin regeneration, wound healing, collagen support and anti-aging. It is not an FDA-approved drug; it appears in over-the-counter cosmetics and as a research or compounded peptide, with most human evidence coming from small topical-skincare studies.
Also: Decorinyl, Decorin-like tetrapeptide
Tripeptide-10 citrulline, sold as Decorinyl, is a small synthetic peptide (four residues, despite the name) designed by the Spanish ingredient maker Lipotec to mimic decorin, a protein that keeps collagen fibers neat and evenly sized. The pitch is better collagen, not more collagen. It is a cosmetic ingredient, not an FDA-approved drug, and almost all of the evidence comes from the company that makes it.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
- GHK-Cu has stronger research evidence (Human Trials) compared to Tripeptide-10 Citrulline (Limited Research).
Detailed Comparison
| Attribute | GHK-Cu | Tripeptide-10 Citrulline |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | GHK has a strong affinity for copper(II) ions and forms the GHK-Cu complex, which is thought to deliver copper to cells for copper-dependent processes such as connective-tissue formation and antioxidant defense. Its most striking documented activity is broad gene-expression modulation: in cultured human cells, GHK shifts the expression of a large fraction of genes, tending to upregulate tissue-repair genes and downregulate some inflammatory pathways. It stimulates fibroblasts to produce collagen and other extracellular-matrix proteins, supports keratinocyte and blood-vessel activity, and shows antioxidant and anti-inflammatory effects in lab models. Importantly, the copper-binding hypothesis does not fully explain these gene effects, and researchers note the precise mechanism is not yet fully understood. | Decorin sits on collagen fibrils and controls how thick they grow and how tightly they pack. With age, decorin activity drops, and collagen fibers become uneven and disorganized, which is part of why older skin loses suppleness. Lipotec researchers took the two short sequences decorin uses to grab collagen, built a library of tetrapeptides around them, and screened them in a test-tube collagen assembly assay. The winner, tripeptide-10 citrulline, made fibrils thinner and more uniform in that assay. The idea is that a well-organized collagen network is more cohesive and supple. Whether a topical cream delivers enough peptide to the dermis to do this in real skin has not been independently shown. |
| Common Dosing | 1-2 mg daily systemically, or 0.05% in cosmetic formulations Once daily | Around 0.01% peptide in a finished product Once or twice daily |
| Administration | Subcutaneous injection or topical application | Topical (serums, creams) |
| Typical Duration | Varies by application | Studies ran 2 months (60 days); ongoing use for maintained effects |
| Best Time to Take | Evening (for skin/recovery) | Morning and/or evening skincare routine |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Much of the mechanistic and efficacy evidence is from cell culture and animal studies. In animals, GHK and GHK-containing dressings improved wound contraction, granulation tissue and collagen deposition in rabbit and rat wounds, and showed protective effects in lung-injury models. In cells, GHK increases collagen, elastin and growth-factor production by fibroblasts and protects keratinocytes from UV damage. Human evidence exists but is limited to small cosmetic trials: facial-cream and eye-cream studies in modest numbers of women (for example a 71-subject facial study and a 41-subject eye-cream study) reported improvements in skin density, thickness and wrinkle appearance. These trials are small and focused on topical skin endpoints, so they do not establish injected or systemic benefits, and there are no large independent randomized trials. Honest summary: strong lab and animal data plus encouraging small topical human studies, but evidence for injected use is preliminary. | The founding paper is Puig, Garcia Anton and Mangues (Lipotec) in the Journal of Cosmetic Science, 2008, which describes the in vitro fibrillogenesis screen. Trade press reporting of the same company work described a 0.01 percent formula applied for two months that made collagen fibers more uniform in a handful of volunteers, and a placebo comparison (22 women on peptide, 21 on placebo) reporting a 54 percent rise in suppleness. Those numbers come from the manufacturer and are not easy to check against full published data. The one independent-looking human trial is Raikou and colleagues, Journal of Cosmetic Dermatology 2017: 24 volunteers split into four groups (combination with acetyl hexapeptide-3, each peptide alone, or neither) for 60 days, with some statistically significant differences in wrinkle microtopography and water loss. Six people per group is very small, and the authors themselves could not explain any synergy. Fair summary: a clever design with real in vitro logic, and thin human data. |
Frequently Asked Questions: GHK-Cu vs Tripeptide-10 Citrulline
What is the difference between GHK-Cu and Tripeptide-10 Citrulline?
GHK-Cu is a skin & hair peptide that ghk-cu is the copper(ii) complex of ghk, a naturally occurring human tripeptide (glycyl-l-histidyl-l-lysine) found in blood plasma, saliva and urine, whose levels decline with age. it is researched and widely used in cosmetic skincare for skin regeneration, wound healing, collagen support and anti-aging. it is not an fda-approved drug; it appears in over-the-counter cosmetics and as a research or compounded peptide, with most human evidence coming from small topical-skincare studies. Tripeptide-10 Citrulline is a skin & hair peptide that tripeptide-10 citrulline, sold as decorinyl, is a small synthetic peptide (four residues, despite the name) designed by the spanish ingredient maker lipotec to mimic decorin, a protein that keeps collagen fibers neat and evenly sized. the pitch is better collagen, not more collagen. it is a cosmetic ingredient, not an fda-approved drug, and almost all of the evidence comes from the company that makes it. The main differences lie in their mechanisms of action and clinical applications.
Which is better, GHK-Cu or Tripeptide-10 Citrulline?
Neither is universally "better" - the choice depends on your specific goals. GHK-Cu is typically used for skin & hair purposes, while Tripeptide-10 Citrulline is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can GHK-Cu and Tripeptide-10 Citrulline be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using GHK-Cu and Tripeptide-10 Citrulline together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.